open access

Vol 7 (2022): Continuous Publishing
Original paper
Published online: 2022-05-20
Get Citation

Assessment of choroid thickness by swept‑source optical coherence tomography (SS-OCT) in patients with posterior uveitis

Abhishek Agarwal1, Shishir Narain1, Charu Gupta1, Priyanka Gupta1, Daraius Shroff1, Cyrus M. Shroff1
·
Ophthalmol J 2022;7:86-93.
Affiliations
  1. Shroff Eye Centre, Kailash Colony, New Delhi, India

open access

Vol 7 (2022): Continuous Publishing
ORIGINAL PAPERS
Published online: 2022-05-20

Abstract

Background: This study aimed to measure the changes in choroid thickness using Swept-Source Optical Coherence Tomography (SS-OCT) after treatment of posterior uveitis along with changes in fundus auto-fluorescence pattern.

Material and methods: This prospective observational cohort study was conducted from December 2018 to May 2020, in which 32 eyes of 20 patients presenting in the out-patient department with a clinical diagnosis of posterior uveitis were enrolled. Best-corrected visual acuity (BCVA) by Snellen chart, intraocular pressure (IOP) Measurement using a non-contact tonometer, choroidal thickness by SS-OCT, and fundus imaging by Fundus Autofluorescence was done. All tests were done at baseline, first follow-up of 2 ± 1 weeks and the second follow-up of 6 ± 2 weeks. Data was compiled and analyzed.

Results: The mean age of patients was 31 ± 6.9 years with M:F of 3:1. During the second follow-up, with the healing of the lesions, there was a significant reduction in the choroidal thickness at all levels by SS-OCT (p < 0.05), with significant improvement in BCVA (0.05 vs. 0.14 vs. 0.31, p < 0.05). IOP increased significantly at the first follow-up to 17.31 from baseline (16.25) (p = 0.032). However, the rise at the second follow-up was not significant (17.03 vs. 16.25 at baseline, p = 0.15). On fundus autofluorescence, normal autofluorescence and hypofluorescence increased at the second follow-up of 6 weeks (p < 0.0001)

Conclusion: SS-OCT showed a significant decrease in the choroidal thickness at all levels during the follow-ups. The healing of the posterior uveitis lesions and fundus autofluorescence became normal simultaneously.

Abstract

Background: This study aimed to measure the changes in choroid thickness using Swept-Source Optical Coherence Tomography (SS-OCT) after treatment of posterior uveitis along with changes in fundus auto-fluorescence pattern.

Material and methods: This prospective observational cohort study was conducted from December 2018 to May 2020, in which 32 eyes of 20 patients presenting in the out-patient department with a clinical diagnosis of posterior uveitis were enrolled. Best-corrected visual acuity (BCVA) by Snellen chart, intraocular pressure (IOP) Measurement using a non-contact tonometer, choroidal thickness by SS-OCT, and fundus imaging by Fundus Autofluorescence was done. All tests were done at baseline, first follow-up of 2 ± 1 weeks and the second follow-up of 6 ± 2 weeks. Data was compiled and analyzed.

Results: The mean age of patients was 31 ± 6.9 years with M:F of 3:1. During the second follow-up, with the healing of the lesions, there was a significant reduction in the choroidal thickness at all levels by SS-OCT (p < 0.05), with significant improvement in BCVA (0.05 vs. 0.14 vs. 0.31, p < 0.05). IOP increased significantly at the first follow-up to 17.31 from baseline (16.25) (p = 0.032). However, the rise at the second follow-up was not significant (17.03 vs. 16.25 at baseline, p = 0.15). On fundus autofluorescence, normal autofluorescence and hypofluorescence increased at the second follow-up of 6 weeks (p < 0.0001)

Conclusion: SS-OCT showed a significant decrease in the choroidal thickness at all levels during the follow-ups. The healing of the posterior uveitis lesions and fundus autofluorescence became normal simultaneously.

Get Citation

Keywords

choroidal thickness; fundus autofluorescence; swept-source optical coherence tomography

About this article
Title

Assessment of choroid thickness by swept‑source optical coherence tomography (SS-OCT) in patients with posterior uveitis

Journal

Ophthalmology Journal

Issue

Vol 7 (2022): Continuous Publishing

Article type

Original paper

Pages

86-93

Published online

2022-05-20

Page views

4663

Article views/downloads

493

DOI

10.5603/OJ.2022.0014

Bibliographic record

Ophthalmol J 2022;7:86-93.

Keywords

choroidal thickness
fundus autofluorescence
swept-source optical coherence tomography

Authors

Abhishek Agarwal
Shishir Narain
Charu Gupta
Priyanka Gupta
Daraius Shroff
Cyrus M. Shroff

References (22)
  1. Vezzola D, Allegrini D, Borgia A, et al. Swept-source optical coherence tomography and optical coherence tomography angiography in acquired toxoplasmic chorioretinitis: a case report. J Med Case Rep. 2018; 12(1): 358.
  2. Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behcet's uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013; 54(9): 6033–6039.
  3. Kishi S. Impact of swept source optical coherence tomography on ophthalmology. Taiwan J Ophthalmol. 2016; 6(2): 58–68.
  4. Samy A, Lightman S, Ismetova F, et al. Role of autofluorescence in inflammatory/infective diseases of the retina and choroid. J Ophthalmol. 2014; 2014: 418193.
  5. Gupta V, Al-Dhibi HA, Arevalo JF. Retinal imaging in uveitis. Saudi J Ophthalmol. 2014; 28(2): 95–103.
  6. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011; 31(3): 510–517.
  7. Copete S, Flores-Moreno I, Montero JA, et al. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol. 2014; 98(3): 334–338.
  8. Adhi M, Liu JJ, Qavi AH, et al. Choroidal analysis in healthy eyes using swept-source optical coherence tomography compared to spectral domain optical coherence tomography. Am J Ophthalmol. 2014; 157(6): 1272–1281.e1.
  9. Bhayana AA, Kumar V, Tayade A, et al. Choroidal thickness in normal Indian eyes using swept-source optical coherence tomography. Indian J Ophthalmol. 2019; 67(2): 252–255.
  10. Rishi P, Akhtar Z, Agrawal R, et al. Choroidal thickness in normal Indian subjects using Swept source optical coherence tomography. PLoS One. 2018; 13(5): e0197457–55.
  11. Jaisankar D, Raman R, Sharma HR, et al. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography. Ocul Immunol Inflamm. 2019; 27(2): 235–243.
  12. Koizumi H, Pozzoni MC, Spaide RF. Fundus autofluorescence in birdshot chorioretinopathy. Ophthalmology. 2008; 115(5): e15–e20.
  13. Haen SP, Spaide RF. Fundus autofluorescence in multifocal choroiditis and panuveitis. Am J Ophthalmol. 2008; 145(5): 847–853.
  14. Cardillo PF, Grosso A, Savini E. Fundus autofluorescence in serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 2009; 247(2): 179–85.
  15. Ayata A, Dogru S, Senol MG, et al. Autofluorescence findings in Vogt-Koyanagi-Harada disease. Eur J Ophthalmol. 2009; 19(6): 1094–1097.
  16. Koizumi H, Maruyama K, Kinoshita S. Blue light and near-infrared fundus autofluorescence in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2010; 94(11): 1499–1505.
  17. Yeh S, Forooghian F, Wong WT, et al. Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol. 2010; 128(1): 46–56.
  18. Spaide RF. Collateral damage in acute zonal occult outer retinopathy. Am J Ophthalmol. 2004; 138(5): 887–889.
  19. Furino C, Boscia F, Cardascia N, et al. Fundus autofluorescence and multiple evanescent white dot syndrome. Retina. 2009; 29(1): 60–63.
  20. Giuliari G, Hinkle DM, Foster CS. The spectrum of fundus autofluorescence findings in birdshot chorioretinopathy. J Ophthalmol. 2009; 2009: 567693.
  21. Bansal R, Basu S, Gupta A, et al. Imaging in tuberculosis-associated uveitis. Indian J Ophthalmol. 2017; 65(4): 264–270.
  22. Ishikawa S, Taguchi M, Muraoka T, et al. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease. Br J Ophthalmol. 2014; 98(11): 1508–1513.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Publisher: VM Media Group sp. z o.o., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 310 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl